The epidemiology of Sjögren’s syndrome

Ruchika Patel, Anupama Shahane Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA Abstract: Sjögren’s syndrome is a chronic systemic autoimmune disease characterized by lymphocytic infiltration of exocrine glands. It can present as an entity by itself, pr...

Full description

Bibliographic Details
Main Authors: Patel R, Shahane A
Format: Article
Language:English
Published: Dove Medical Press 2014-07-01
Series:Clinical Epidemiology
Online Access:http://www.dovepress.com/the-epidemiology-of-sjoumlgrenrsquos-syndrome-peer-reviewed-article-CLEP
_version_ 1818528996982259712
author Patel R
Shahane A
author_facet Patel R
Shahane A
author_sort Patel R
collection DOAJ
description Ruchika Patel, Anupama Shahane Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA Abstract: Sjögren’s syndrome is a chronic systemic autoimmune disease characterized by lymphocytic infiltration of exocrine glands. It can present as an entity by itself, primary Sjögren's syndrome (pSS), or in addition to another autoimmune disease, secondary Sjögren's syndrome (sSS). pSS has a strong female propensity and is more prevalent in Caucasian women, with the mean age of onset usually in the 4th to 5th decade. Clinical presentation varies from mild symptoms, such as classic sicca symptoms of dry eyes and dry mouth, keratoconjunctivitis sicca, and xerostomia, to severe systemic symptoms, involving multiple organ systems. Furthermore, a range of autoantibodies can be present in Sjögren's syndrome (anti-SSA/Ro and anti-SSB/La antibodies, rheumatoid factor, cryoglobulins, antinuclear antibodies), complicating the presentation. The heterogeneity of signs and symptoms has led to the development of multiple classification criteria. However, there is no accepted universal classification criterion for the diagnosis of Sjögren's syndrome. There are a limited number of studies that have been published on the epidemiology of Sjögren's syndrome, and the incidence and prevalence of the disease varies according to the classification criteria used. The data is further confounded by selection bias and misclassification bias, making it difficult for interpretation. The aim of this review is to understand the reported incidence and prevalence on pSS and sSS, the frequency of autoantibodies, and the risk of malignancy, which has been associated with pSS, taking into account the different classification criteria used. Keywords: Sjögren's syndrome, incidence, prevalence, classification criteria, autoantibodies, lymphoma
first_indexed 2024-12-11T06:57:21Z
format Article
id doaj.art-8829e1e955c749b2a4d279ff34d809e0
institution Directory Open Access Journal
issn 1179-1349
language English
last_indexed 2024-12-11T06:57:21Z
publishDate 2014-07-01
publisher Dove Medical Press
record_format Article
series Clinical Epidemiology
spelling doaj.art-8829e1e955c749b2a4d279ff34d809e02022-12-22T01:16:44ZengDove Medical PressClinical Epidemiology1179-13492014-07-012014default24725517774The epidemiology of Sjögren’s syndromePatel RShahane ARuchika Patel, Anupama Shahane Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA Abstract: Sjögren’s syndrome is a chronic systemic autoimmune disease characterized by lymphocytic infiltration of exocrine glands. It can present as an entity by itself, primary Sjögren's syndrome (pSS), or in addition to another autoimmune disease, secondary Sjögren's syndrome (sSS). pSS has a strong female propensity and is more prevalent in Caucasian women, with the mean age of onset usually in the 4th to 5th decade. Clinical presentation varies from mild symptoms, such as classic sicca symptoms of dry eyes and dry mouth, keratoconjunctivitis sicca, and xerostomia, to severe systemic symptoms, involving multiple organ systems. Furthermore, a range of autoantibodies can be present in Sjögren's syndrome (anti-SSA/Ro and anti-SSB/La antibodies, rheumatoid factor, cryoglobulins, antinuclear antibodies), complicating the presentation. The heterogeneity of signs and symptoms has led to the development of multiple classification criteria. However, there is no accepted universal classification criterion for the diagnosis of Sjögren's syndrome. There are a limited number of studies that have been published on the epidemiology of Sjögren's syndrome, and the incidence and prevalence of the disease varies according to the classification criteria used. The data is further confounded by selection bias and misclassification bias, making it difficult for interpretation. The aim of this review is to understand the reported incidence and prevalence on pSS and sSS, the frequency of autoantibodies, and the risk of malignancy, which has been associated with pSS, taking into account the different classification criteria used. Keywords: Sjögren's syndrome, incidence, prevalence, classification criteria, autoantibodies, lymphomahttp://www.dovepress.com/the-epidemiology-of-sjoumlgrenrsquos-syndrome-peer-reviewed-article-CLEP
spellingShingle Patel R
Shahane A
The epidemiology of Sjögren’s syndrome
Clinical Epidemiology
title The epidemiology of Sjögren’s syndrome
title_full The epidemiology of Sjögren’s syndrome
title_fullStr The epidemiology of Sjögren’s syndrome
title_full_unstemmed The epidemiology of Sjögren’s syndrome
title_short The epidemiology of Sjögren’s syndrome
title_sort epidemiology of sj ouml gren rsquo s syndrome
url http://www.dovepress.com/the-epidemiology-of-sjoumlgrenrsquos-syndrome-peer-reviewed-article-CLEP
work_keys_str_mv AT patelr theepidemiologyofsjoumlgrenrsquossyndrome
AT shahanea theepidemiologyofsjoumlgrenrsquossyndrome
AT patelr epidemiologyofsjoumlgrenrsquossyndrome
AT shahanea epidemiologyofsjoumlgrenrsquossyndrome